Mass Medical Angels

Mass Medical Angels

Mass Medical Angels formed in 2005 when a group of Boston doctors and biotech operators organized to invest directly in early-stage healthcare companies. The group built a membership of accredited physician-investors and industry executives, many affiliated with Harvard Medical School, Massachusetts General Hospital, and the Broad Institute, establishing a sourcing network that combines clinical practice visibility with deal-flow access across the Massachusetts life-sciences corridor. The group makes seed and Series A investments into therapeutics, medical devices, diagnostics, and health IT. MA2 syndicates individual member capital per-deal rather than pooling a single fund, a structure that lets members opt into opportunities they can evaluate clinically. Known portfolio companies include OvaScience, a fertility-focused biotech that went public in 2012 (public record), and Seventh Sense Biosystems, a blood-collection device maker that raised multiple venture rounds before a commercial exit. The group co-invests alongside Boston-area healthcare venture firms and accelerator graduates, primarily in US and European companies. MA2 operates chapters in Cambridge, Massachusetts, and maintains points of presence in Ingelheim, Germany, and Tokyo, Japan, reflecting the transatlantic and transpacific networks of its member base. The group does not publicly disclose total capital deployed or membership counts. Its model runs adjacent to the Mass Medical Society and regional innovation initiatives like the Massachusetts Life Sciences Center, but the group itself is a member-managed angel syndicate rather than a venture firm or foundation. The group's structural edge is the clinical-decision membership model: every investor is an active or former healthcare practitioner or life-science executive. That design embeds technical due-diligence capability directly into the capital-allocation process, a differentiator from generalist angel networks that rely on external advisors for domain expertise.